Monday, May 4, 2009

Ranbaxy starts phase-III trials for its new anti-malarial molecule

Ranbaxy Laboratories Limited started phase-III clinical trials for its new anti-malaria combination drug, arterolane maleate + piperaquine phosphate in India, Bangladesh and Thailand.

the details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)